Moneycontrol PRO
Open App
you are here: HomeNewsTrends

India’s COVID-19 anxiety score highest in world: Report

India has been occupying the top spot since the first survey was conducted by Deloitte in April.

May 28, 2020 / 01:35 PM IST
Representational Image (Wallpaper Flare)

Representational Image (Wallpaper Flare)

Indian consumers are the most worried people across the world on the uncertainties that lie ahead due to the coronavirus lockdown, Business Line reported quoting a survey conducted by Deloitte on May 16.

During the survey, respondents aged above 18 years were asked if they felt more anxious than last week.

For live updates on coronavirus, click here

India ranked highest in this global anxiety index, with a score of 33. The next in line was Mexico at 17, followed by Spain at 14 – both scores remarkably less than India’s.

During a previous survey conducted on May 3, India’s score was 57. This means the anxiety level of Indians has since reduced.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Notably, India has been occupying the top spot since the first survey was conducted in April. In the meantime, countries like Japan and Italy, which topped the charts in the first half of May, moved down several spots on the index.

Commenting on the results, Anil Talreja, Partner, Consumer Industry, Deloitte India, said: “The survey gives a pulse of consumer behaviour and trends during these challenging times. It gives a reflection of heightened consumer apprehensions, which are at the core of their decision-making. This, in turn, will also steer consumer product companies to build their new strategies around sales and marketing. Building value for brands virtually is going to be another task that companies would need to focus on in future.”

The first such survey was undertaken on April 13 across 13 countries. The target was to reach out to 1,000 respondents in each nation, who would represent the entire population.

To follow our full coverage on coronavirus, click here
Moneycontrol News
first published: May 28, 2020 01:35 pm
ISO 27001 - BSI Assurance Mark